Level Four Advisory Services, LLC Repligen Corp Transaction History

Level Four Advisory Services, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $5,123 - $6,252	30 Added 2.51%	1,227 $225,000
Q4 2023 Feb 08, 2024	BUY	$114.17 - $185.35 $136,661 - $221,863	1,197 New	1,197 $215,000
Q3 2022 Nov 07, 2022	BUY	$160.42 - $256.21 $413,723 - $660,765	2,579 New	2,579 $483,000
Q2 2022 Aug 08, 2022	SELL	$140.68 - $188.02 $363,376 - $485,655	-2,583 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $402,491 - $644,126	-2,497 Reduced 49.15%	2,583 $486,000
Q4 2021 Feb 11, 2022	BUY	$247.59 - $304.47 $755,397 - $928,937	3,051 Added 150.37%	5,080 $1.35 Million
Q3 2021 Oct 12, 2021	BUY	$194.77 - $324.21 $5,453 - $9,077	28 Added 1.4%	2,029 $586,000
Q2 2021 Aug 09, 2021	BUY	$165.87 - $220.95 $35,164 - $46,841	212 Added 11.85%	2,001 $399,000
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $124,094 - $155,666	688 Added 62.49%	1,789 $348,000
Q4 2020 Feb 10, 2021	BUY	$148.08 - $206.57 $163,036 - $227,433	1,101 New	1,101 $211,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Level Four Advisory Services, LLC with notifications on news.